Mirae Asset Global ETFs Holdings
MRNA icon

Mirae Asset Global ETFs Holdings’s Moderna MRNA Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.46M Sell
106,564
-41,025
-28% -$2.12M 0.01% 753
2026
Q1 		$7.48M Buy
147,589
+2,935
+2% +$137K 0.01% 718
2025
Q4 		$4.28M Buy
144,654
+28,016
+24% +$761K 0.01% 851
2025
Q3 		$3M Sell
116,638
-5,271
-4% -$147K ﹤0.01% 969
2025
Q2 		$3.36M Buy
121,909
+18,755
+18% +$494K 0.01% 864
2025
Q1 		$2.96M Buy
103,154
+136
+0.1% +$4.83K 0.01% 937
2024
Q4 		$4.26M Sell
103,018
-192,303
-65% -$9.19M 0.01% 825
2024
Q3 		$19.7M Sell
295,321
-8,935
-3% -$820K 0.04% 369
2024
Q2 		$36.1M Buy
+304,256
New +$38.5M 0.09% 230

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's MRNA Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings reduced its Moderna (MRNA) stake by 28% in Q2 2026, selling an estimated $2.12M and leaving 106,564 shares worth $7.46M. The position accounts for 0.01% of the portfolio, ranked #753.

Mirae Asset Global ETFs Holdings first reported a position in MRNA in Q2 2024 and has held it in 9 quarters since. The position peaked at $36.1M in Q2 2024. 784 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 106,564 shares of Moderna worth $7.46M as of Q2 2026.
  • Mirae Asset Global ETFs Holdings sold 41,025 Moderna shares in Q2 2026, an estimated $2.12M.
  • Moderna made up 0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #753 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Moderna in Q2 2024 and has held it in 9 quarters since.
  • Mirae Asset Global ETFs Holdings's Moderna position peaked at $36.1M in Q2 2024.
  • 784 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.